文献速递小儿神经外科与脑积水

经逆行脑室-静脉窦分流治疗脑积水:前瞻性临床研究

Treating Hydrocephalus with Retrograde Ventriculosinus Shunt: Prospective Clinical Study.
PubMed 文献 · World Neurosurg · 2018-06-25

单中心前瞻性临床研究纳入10例患者植入El-Shafei式逆行脑室-静脉窦分流,含4例作为挽救手术。植入可行并能实现生理性脑脊液引流,但14例中仅3例在超过6年随访中维持分流功能。作者认为失败与现有静脉通路装置植入困难及易阻塞有关,并提出新型硬脑膜静脉窦通路装置。

要点

  • 逆行脑室-静脉窦分流植入可行,可实现生理性脑脊液引流。
  • 14例中仅3例在超过6年随访中维持分流功能。
  • 作者认为失败原因为现有静脉通路装置植入困难和易阻塞。

核心结论

  • 在逆行脑室-静脉窦分流成为常规实践前,需开发易于植入且抗血栓的硬脑膜静脉窦通路装置。

研究设计与样本

  • 单中心前瞻性临床研究,10例患者植入El-Shafei式逆行脑室-静脉窦分流,其中4例为挽救手术。

主要发现

  • 逆行脑室-静脉窦分流植入可行,可实现脑脊液生理性引流。
  • 14例患者中仅3例在超过6年随访中维持逆行脑室-静脉窦分流功能。
  • 作者认为这些分流失败的原因是现有静脉通路装置难以正确植入且过于容易阻塞。

临床怎么用

  • 作者认为在逆行脑室-静脉窦分流成为常规实践前,需开发易于植入且抗血栓的硬脑膜静脉窦通路装置。

局限性

  • 单中心研究,样本量为10例患者。
  • 14例中仅3例在超过6年随访中维持分流功能,作者认为分流失败与现有静脉通路装置有关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since the 1950s, hydrocephalus has been be treated with cerebrospinal fluid (CSF) shunts, usually to the peritoneal cavity or to the right cardiac atrium. However, because of their siphoning effect, these shunts lead to nonphysiologic CSF drainage, with possible comorbidity and high revision rates. More sophisticated shunt valve systems significantly increase costs and technical complexity and remain unsuccessful in a subgroup of patients. In an attempt to obtain physiologic CSF shunting, many neurosurgical pioneers shunted towards the dural sinuses, taking advantage of the physiologic antisiphoning effect of the internal jugular veins. Despite several promising reports, the ventriculosinus shunts have not yet become standard neurosurgical practice. METHODS: In this single-center prospective clinical study, we implanted the retrograde ventriculosinus shunt, as advocated by El-Shafei, in 10 patients. This article reports on our operation technique and long-term outcome, including 4 patients in whom this shunt was implanted as a rescue operation. RESULTS: Implantation of a ventriculosinus shunt proved to be feasible, warranting physiologic drainage of CSF. However, in only 3 of 14 patients, functionality of the retrograde ventriculosinus shunt was maintained during more than 6 years of follow-up. In our opinion, these shunts fail because present venous access devices are difficult to implant correctly and become too easily obstructed. After discussion of possible causes of this frequent obstruction, a new dural venous sinus access device is presented. CONCLUSION: An easy-to-implant and thrombogenic-resistant dural venous sinus access device needs to be developed before ventriculosinus shunting can become general practice.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Baert EJ, Dewaele F, Vandersteene J, et al. Treating Hydrocephalus with Retrograde Ventriculosinus Shunt: Prospective Clinical Study. World Neurosurg. 2018. PMID: 29953953. doi:10.1016/j.wneu.2018.06.097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。